Clinical Trial Update: Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for everolimus in women with breast cancer that can be removed by surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | Phase 2 | Status: WITHDRAWN